Nermeen Varawalla

Company: Scancell

Job title: Chief Medical Officer

Seminars:

Smart Design of Neoantigen Vaccine Clinical Development 4:45 pm

Selecting the cancer type, disease setting and patient subpopulation Determining dosing schedules, mode of administration and alignment with standard of care Deciding on endpoints of immune and clinical response to demonstrate improvements over standard of careRead more

day: Day One

Identifying Rational, Synergistic Neoantigen Combination Strategies to Maximise Clinical Efficacy & Overcome Tumour Resistance to Improve Patient Response Rate 9:01 am

Helping the industry to overcome challenges in efficacy and tumour resistance, combination strategies have been hailed the future of immunotherapy, with neoantigen-targeted cell therapies and vaccines increasingly being administered alongside other immunotherapies. However, navigating the complexity of administering multiple drugs requires smart protocol design, identification of distinct biomarkers, careful monitoring of toxicity, and precise assays…Read more

day: Pre-Conference Day